Schulman Associates IRB Establishes Itself in Canada
Cincinnati, OH-Oct. 27, 2009
Schulman Associates IRB (Schulman) has expanded its IRB services into Canada with an office in Toronto because of requests from clients, according to the company. The Schulman Canadian Board’s first official meeting is scheduled for this week.
For North American studies which are conducted in both the U.S. and Canada, Canadian and U.S. Board members will review the research together in order to maintain consistency.
“Our clients have asked us to provide review services in Canada. Now that our Canadian IRB is operational, Schulman can provide the same...review for Canadian research as it has provided in the U.S. for the past 26 years,” said Schulman’s CEO, John Isidor.
Schulman provides clients conducting Canadian studies with access to its WebPortal 2.0 service. WebPortal 2.0 interfaces directly with Schulman’s internal system to provide Sponsors and CROs with real-time updates on review status and timelines.
Early next year, Schulman will launch updated electronic tools to provide clients with greater access to critical review information. Schulman’s existing submission forms have been revised to comply with Canadian regulations and terminology. The revisions are minor and the forms will remain familiar to Schulman clients who have used them for U.S. studies.
French-speaking support is available for Canadian studies. Schulman’s U.S. institutional review board is fully accredited by the Association for Accreditation of Human Research Protection Programs (AAHRPP).
For more information on Schulman call Client Services at 513-761-4100 or visit www.sairb.com.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Using Patient Reported Outcomes in Dermatology Trials
April 25th 2024In part 3 of this video interview with ACT editor Andy Studna, Melissa Mooney, director, eCOA sales engineering, IQVIA sheds light on the unique challenges of dermatology trials and how clinical outcome assessments can be implemented in them.
Improving Engagement While Maintaining Data Integrity & Validity
March 19th 2024In recognition of Women's Health Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and uMotif's Chief Product Officer, Julia Lakeland, discuss new technologies improving patient engagement and reducing the emotional and logistical burdens of participation, ethical considerations that should be addressed when implementing those technologies, while ensuring patient privacy, and much more.
